Treatment with Specified Products
Dear Bedfordshire Hospitals NHS Foundation Trust,
Could you please provide answers to the following questions, with regards to treatments with the specified products:
1) in the past 6 months, how many patients were treated with a combination of both Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following diseases:
A) Metastatic Melanoma
B) Colorectal Cancer
C) Any other indications
2) In the past 6 months, how many patients were treated with a combination of Dabrafenib + Trametinib for the following diseases:
A) Metastatic Melanoma
B) Adjuvant Melanoma
C) BRAF mutated Lung Cancer
Thank you for answering these questions
Yours faithfully,
BEN HOLDSWORTH
Dear Requester
FOI 2839
I acknowledge receipt of your request under the Freedom of Information (FOI) Act, and you can expect the Trust's response on or by 20/02/2024.
Kind regards,
Freedom of Information Officer
Bedfordshire Hospitals NHS Foundation Trust
Dear Requester
Please find attached the response to your recent FOI request, thank you.
Aimée Moore
Deputy Information Governance Manager
Bedfordshire Hospitals NHS Foundation Trust
[mobile number]
Visit: http://www.bedfordshirehospitals.nhs.uk/
Advanced notice of leave:
2nd February - 5th February 2024
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now